- $155.61bn
- $204.48bn
- $63.63bn
- 98
- 84
- 91
- 100
Pfizer Inc Pfizer Receives Approval From European Commission For Pending Acquisi
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc Significantly More Smokers With
AnnouncementPfizer Inc - Lipitor Provides Greater Benefit Compared to simvastatin in Patient
AnnouncementPfizer Inc - New Lipitor Data Analyses from Landmark Ideal and SPARCL Trials to
AnnouncementPfizer Inc - Pfizer joint with Monogram.
AnnouncementPfizer Inc - DOJ Announcement
AnnouncementPfizer Inc - Pfizer Invites Public to View and Listen to Webcast of Pfizer Parti
AnnouncementPfizer Inc - FDA Advisory Committee Recommends Approval Of Exubera
AnnouncementPfizer Inc - FDA Advisory Committee Recommends Approval Of Exubera
AnnouncementPfizer Inc Pfizer And Medivation Announce Results
AnnouncementPfizer Inc - Pfizer to Share New Data and Portfolio Update on Infectious Disease
AnnouncementPfizer Inc - Pfizer Obtains Clearance from Federal Cartel Office of Germany for
AnnouncementPfizer Inc - 1st Quarter Results
AnnouncementPfizer Inc - Post-Stroke Patients Treated with Lipitor Demonstrated Significant
AnnouncementPfizer Inc - Webcast
AnnouncementPfizer Inc - Pfizer Clears U.S. Antitrust Review for Acquisition of All Outstand
AnnouncementPfizer Inc - Acquisition(s)
AnnouncementPfizer Inc - Research Update
Announcement